SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-021328
Filing Date
2022-08-04
Accepted
2022-08-04 16:16:40
Documents
2
Period of Report
2022-07-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3937
2 ex24.htm EX-24 11063
  Complete submission text file 0001493152-22-021328.txt   16495
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RITTER PHARMACEUTICALS INC. 1801 CENTURY PARK EAST, SUITE 1820 LOS ANGELES CA 90096
Business Address
Ritter Ira E. (Reporting) CIK: 0001631674 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37428 | Film No.: 221136797